The activation or upregulation of NF-κB via multiple routes, including but not limited to the TME, tumor-associated macrophages, or oncogenic mutations in KRAS, has been shown to favor cancer tumorigenesis, angiogenesis, and metastasis [40]. The gene discussed is KRAS; the disease is cancer.